Shanghai Yizhong Pharmaceutical Co., Ltd.

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

437

Website

www.yizhongpharma.com

Country

China

Exchange

Shanghai

Founded 2009Shanghai, China

Shanghai Yizhong Pharmaceutical develops anti-tumor drugs and related products in China. It also offers paclitaxel polymer nanomicelles for the treatment of non-small cell lung cancer, as well as various types of cancer

Including esophageal cancer, gastric cancer, nasopharyngeal carcinoma, pancreatic cancer, breast cancer, gynecological tumors, etc. Founded in 2009, the company is headquartered in Shanghai, China.

Key Stats

52-Week Range

¥35.95¥83.60

Beta-0.49

Trailing P/E107.24

Forward P/EN/A

Trailing EPS0.34

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.